Cargando…
Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
INTRODUCTION: In cognitively normal (CN) adults, increased rates of amyloid beta (Aβ) accumulation can be detected in low Aβ (Aβ–) apolipoprotein E (APOE) ε4 carriers. We aimed to determine the effect of ε4 on the ability to benefit from experience (ie, learn) in Aβ– CNs. METHODS: Aβ– CNs (n = 333)...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962170/ https://www.ncbi.nlm.nih.gov/pubmed/33748392 http://dx.doi.org/10.1002/dad2.12136 |
_version_ | 1783665416681291776 |
---|---|
author | Lim, Yen Ying Baker, Jenalle E. Mills, Andrea Bruns, Loren Fowler, Christopher Fripp, Jurgen Rainey‐Smith, Stephanie R. Ames, David Masters, Colin L Maruff, Paul |
author_facet | Lim, Yen Ying Baker, Jenalle E. Mills, Andrea Bruns, Loren Fowler, Christopher Fripp, Jurgen Rainey‐Smith, Stephanie R. Ames, David Masters, Colin L Maruff, Paul |
author_sort | Lim, Yen Ying |
collection | PubMed |
description | INTRODUCTION: In cognitively normal (CN) adults, increased rates of amyloid beta (Aβ) accumulation can be detected in low Aβ (Aβ–) apolipoprotein E (APOE) ε4 carriers. We aimed to determine the effect of ε4 on the ability to benefit from experience (ie, learn) in Aβ– CNs. METHODS: Aβ– CNs (n = 333) underwent episodic memory assessments every 18 months for 108 months. A subset (n = 48) completed the Online Repeatable Cognitive Assessment‐Language Learning Test (ORCA‐LLT) over 6 days. RESULTS: Aβ– ε4 carriers showed significantly lower rates of improvement on episodic memory over 108 months compared to non‐carriers (d = 0.3). Rates of learning on the ORCA‐LLT were significantly slower in Aβ– ε4 carriers compared to non‐carriers (d = 1.2). DISCUSSION: In Aβ– CNs, ε4 is associated with a reduced ability to benefit from experience. This manifested as reduced practice effects (small to moderate in magnitude) over 108 months on the episodic memory composite, and a learning deficit (large in magnitude) over 6 days on the ORCA‐LLT. Alzheimer's disease (AD)–related cognitive abnormalities can manifest before preclinical AD thresholds. |
format | Online Article Text |
id | pubmed-7962170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79621702021-03-19 Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid Lim, Yen Ying Baker, Jenalle E. Mills, Andrea Bruns, Loren Fowler, Christopher Fripp, Jurgen Rainey‐Smith, Stephanie R. Ames, David Masters, Colin L Maruff, Paul Alzheimers Dement (Amst) Cognitive & Behavioral Assessment INTRODUCTION: In cognitively normal (CN) adults, increased rates of amyloid beta (Aβ) accumulation can be detected in low Aβ (Aβ–) apolipoprotein E (APOE) ε4 carriers. We aimed to determine the effect of ε4 on the ability to benefit from experience (ie, learn) in Aβ– CNs. METHODS: Aβ– CNs (n = 333) underwent episodic memory assessments every 18 months for 108 months. A subset (n = 48) completed the Online Repeatable Cognitive Assessment‐Language Learning Test (ORCA‐LLT) over 6 days. RESULTS: Aβ– ε4 carriers showed significantly lower rates of improvement on episodic memory over 108 months compared to non‐carriers (d = 0.3). Rates of learning on the ORCA‐LLT were significantly slower in Aβ– ε4 carriers compared to non‐carriers (d = 1.2). DISCUSSION: In Aβ– CNs, ε4 is associated with a reduced ability to benefit from experience. This manifested as reduced practice effects (small to moderate in magnitude) over 108 months on the episodic memory composite, and a learning deficit (large in magnitude) over 6 days on the ORCA‐LLT. Alzheimer's disease (AD)–related cognitive abnormalities can manifest before preclinical AD thresholds. John Wiley and Sons Inc. 2021-03-16 /pmc/articles/PMC7962170/ /pubmed/33748392 http://dx.doi.org/10.1002/dad2.12136 Text en © 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Cognitive & Behavioral Assessment Lim, Yen Ying Baker, Jenalle E. Mills, Andrea Bruns, Loren Fowler, Christopher Fripp, Jurgen Rainey‐Smith, Stephanie R. Ames, David Masters, Colin L Maruff, Paul Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title | Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title_full | Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title_fullStr | Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title_full_unstemmed | Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title_short | Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid |
title_sort | learning deficit in cognitively normal apoe ε4 carriers with low β‐amyloid |
topic | Cognitive & Behavioral Assessment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962170/ https://www.ncbi.nlm.nih.gov/pubmed/33748392 http://dx.doi.org/10.1002/dad2.12136 |
work_keys_str_mv | AT limyenying learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT bakerjenallee learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT millsandrea learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT brunsloren learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT fowlerchristopher learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT frippjurgen learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT raineysmithstephanier learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT amesdavid learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT masterscolinl learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid AT maruffpaul learningdeficitincognitivelynormalapoee4carrierswithlowbamyloid |